To the Editor: As a recent graduate of residency and fellowship in psychiatry, I read the article by David B. Merrill, M.D., et al. (1) with great interest. I struggled to define my relationship with the pharmaceutical industry throughout residency, as did most of my classmates in our program at Cambridge Hospital. I have not chosen a research-focused career, and I have great admiration for those who struggle to find funding and collaborate with industry. However, I do have one question that I was unable to answer from reading the article: What ultimately happened to the authors' finding that the study drug, aripiprazole, and control drug, haloperidol, showed no significant difference in efficacy? They refer to a study, but there is no corresponding publication citation.